Dosing

OPDIVO is administered as IV infusion over 30 minutes or subcutaneously over 3 – 5 minutes, followed by chemotherapy* on the same day.

Choice of two dosing options: q2w or q3w.

Treat until disease progression or unacceptable toxicity, or up to 2 years.

Reference:

7356-NO-2500069 / Developed 11.11.2025